Jeswin Joseph

Biography

Education and Training

• BSc , Microbiology
  Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham University
• MSc, Microbiology
  Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham University
• PhD, Molecular Virology
  Indian Institute of Science Education and Research (IISER), Thiruvananthapuram
• Postdoc, Molecular Virology
  Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health

Awards and Honors

• Harvard Catalyst Grant, 2024
  Harvard University
• FEMS Conference Attendance Grant, 2022
  FEMS Conference
• International Travel Grant , 2022
  Department of Science and Technology, Science Engineering Research Board (SERB), Government of India
• Best Oral Presentation Award -Microbiology/Virology , 2022
  International Conference of Advanced Biology-2022(ICAB)
• Innovation in Science Pursuit for Inspired Research (INSPIRE)” PhD Scholarship, 2018 - 2023
  Government of India
• Joint CSIR-UGC Junior Research scholarship, 2017
  Government of India
• Graduate Aptitude Test in Engineering (GATE) in Life sciences and Biotechnology, 2017
  Government of India
• Indian Academy of Science (IAS) Summer Research Fellowship , 2015 - 2016
  Indian Institute of Science, Bangalore
• BSc. and MSc. in Microbiology Gold Medal Winner , 2015 - 2017
  Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham University, Kerala, India

Publications

• MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies.

  Abiona OM, Wang N, Leist SR, Schäfer A, Cockrell AS, Wang L, Bangaru S, Stevens L, Graham RL, Kocher JF, Tsybovsky Y, Kanekiyo M, Kumar A, Morabito KM, Rosen O, Shi W, Werner A, Zhang Y, Ziwawo C, Dzuvor CKO, Palandjian C, Eastman C, Matthews HR, Joseph J, Chappell JD, Kong WP, Mascola JR, Ward AB, Denison MR, Baric R, McLellan JS, Graham BS, Corbett-Helaire KS. iScience 2025 Feb 21

  PMID: 39898019

• SARS-CoV-2 neutralizing antibody epitopes are overlapping and highly mutated which raises the chances of escape variants and requires development of broadly reactive vaccines.

  Joseph J, Darpe S, Kulkarni G, Raj VS. Proteins 2023

  PMID: 36912191

• The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.

  Joseph J, Karthika T, Das VRA, Raj VS. Curr Pharm Biotechnol 2025

  PMID: 34375189

• SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.

  Karthika T, Joseph J, Das VRA, Nair N, Charulekha P, Roji MD, Raj VS. Cells 2021 Jul 17

  PMID: 34359983

• Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses.

  Joseph J, Karthika T, Das VRA, Raj VS. J Glob Antimicrob Resist 2021

  PMID: 34052520